Trial Profile
A Phase II Study of Caelyx [doxorubicin liposomal] in the Treatment of Advanced Gastric Cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 02 Jun 2015
Price :
$35
*
At a glance
- Drugs Doxorubicin liposomal (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 10 Sep 2005 New trial record.